SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,870,000 | -27.9% | 11,007 | -51.5% | 0.13% | -15.0% |
| Q4 2019 | $2,592,000 | +82.0% | 22,682 | +16.6% | 0.15% | +51.5% |
| Q1 2019 | $1,424,000 | +14.0% | 19,447 | +3.3% | 0.10% | +16.1% |
| Q2 2018 | $1,249,000 | +6.5% | 18,817 | -16.0% | 0.09% | +6.1% |
| Q1 2018 | $1,173,000 | +26.0% | 22,406 | +28.8% | 0.08% | -19.6% |
| Q4 2017 | $931,000 | +311.9% | 17,397 | +318.3% | 0.10% | +78.9% |
| Q3 2017 | $226,000 | -31.1% | 4,159 | -20.3% | 0.06% | +35.7% |
| Q1 2017 | $328,000 | -47.5% | 5,218 | -66.3% | 0.04% | -48.8% |
| Q2 2016 | $625,000 | -52.8% | 15,469 | -47.5% | 0.08% | -29.9% |
| Q4 2015 | $1,323,000 | +60.4% | 29,480 | +37.8% | 0.12% | +64.8% |
| Q3 2015 | $825,000 | +42.5% | 21,400 | +30.5% | 0.07% | +20.3% |
| Q1 2015 | $579,000 | -33.7% | 16,400 | -39.7% | 0.06% | -61.7% |
| Q4 2014 | $873,000 | – | 27,200 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |